Clinical Trials Browser

Interventional × bemarituzumab × Thoracic × Clear all

NCT05267470 2025-03-25

FORTITUDE-201

Phase 1 Terminated

74 enrolled 22 charts

Squamous-Cell Non-Small-Cell Lung Cancer